The following is a summary of “First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 ...

NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural ...

To assess whether NK cells were involved in antitumor response generated by fasting, Delconte and her team depleted these ...

NKGen Biotech (NKGN) announced the administration of troculeucel, an expanded autologous NK cell therapy, in an FTD patient under a single ...

A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage in tumor cells, activates natural killer (NK) cells to suppress tumor ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Cytovia Therapeutics is uniquely positioned to deliver on the therapeutic promise through its plug-and-play cell therapy platform and complementary bispecific NK cell engagers. NK cells readily ...

Biomissile Pharmaceuticals Co. Ltd. is developing multispecific antibodies that overcome resistance associated with antibody-drug conjugates via its next-generation natural killer (NK) cell engagers. ...

One of the lead candidates in Sanofi natural killer (NK) cell engager alliance with Innate Pharma has shown encouraging and durable efficacy in various haematological cancers, according to a phase ...

FREEHOLD, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precision diagnostics and laboratory services ...